Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
| The Manila Times
**media[1067783]**At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment analysis.